Severe respiratory disease associated with Middle East respiratory syndrome coronavirus - 21st update, 21 October 2015
This 21st update of ECDC’s risk assessment on MERS-CoV has been triggered by an increase in MERS cases acquired through nosocomial transmission in Amman, Jordan.
Rapid risk assessment: Severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV). Eleventh update, 21 August 2014
This eleventh updated rapid risk assessment on MERS-CoV shows that the number of cases has been steadily declining in the last few months.
Rapid Risk Assessment: Severe respiratory disease associated with a novel coronavirus
New and noteworthy in this update: the retrospective identification of novel coronavirus in biological samples from two fatal cases in Jordan (April 2012) and the results of a joint ECDC/WHO survey which confirms that EU/EEA Member States have an adequate capacity to detect novel coronavirus through their network of national reference laboratories: 18 of 30 in EU/EEA countries are capable of confirming positive screened samples by either ORF1b RT-PCR or other target RT-PCR assays with sequence analysis or whole-genome sequence analysis.